KATELYN MCCORMACK: Open Payments
NPI 1184889057 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,558 in 319 payments from 41 companies in 2025. Trend: 2023 $25,700 · 2024 $29,463 · 2025 $31,558
Speaker / faculty: $22,114Food & beverage: $5,884Travel & lodging: $3,020Consulting: $441Education: $99
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 27 | $12,093 |
| TG Therapeutics, Inc. | 32 | $7,143 |
| Genentech USA, Inc. | 26 | $6,019 |
| GENZYME CORPORATION | 10 | $1,981 |
| Biogen, Inc. | 6 | $511 |
| ABBVIE INC. | 18 | $389 |
| Amgen Inc. | 33 | $334 |
| PFIZER INC. | 17 | $294 |
| UCB, Inc. | 15 | $248 |
| Mallinckrodt Hospital Products Inc. | 7 | $245 |
Products named: Mavenclad, BRIUMVI, Ocrevus, BOTOX, VUMERITY, UPLIZNA, ACTHAR, Ocrevus Zunovo.
Industry payments across NY — which companies pay providers there.
